Pediatric chronic myeloid leukemia is a unique disease that requires a different approach

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution2012 · 52 citations
2. 2JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo2014 · 159 citations
3. 3Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial2011 · 166 citations
4. 4Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia2015 · 49 citations
5. 5JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia2013 · 99 citations